SCHEMBL3846793

SCHEMBL3846793

COc1nnc(-c2ncnc3ccc(-c4c[nH]nc4-c4c(F)cccc4F)cc23)o1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 3/20 0.36
RAF1 P04049 4/20 0.35
BRAF P15056 4/20 0.35
NOTUM Q6P988 1/20 0.35
DYRK1A Q13627 4/20 0.35
CCNT1 O60563 1/20 0.35
GSK3B P49841 1/20 0.35
CDK9 P50750 1/20 0.35
CYP1A2 P05177 5/20 0.33
CYP2D6 P10635 5/20 0.33
CYP2C19 P33261 5/20 0.33
LMNA P02545 4/20 0.33
CYP3A4 P08684 4/20 0.33
CLK4 Q9HAZ1 4/20 0.33
TSHR P16473 3/20 0.33
ALDH1A1 P00352 3/20 0.33
HSD17B10 Q99714 3/20 0.33
USP2 O75604 3/20 0.33
HPGD P15428 2/20 0.33
MAPK1 P28482 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3845615 0.79 MAP4K4 (0.33) MAP4K4RAF1BRAFNOTUMCYP1A2
SCHEMBL3850421 0.76 MAP4K4 (0.38) MAP4K4RAF1BRAFDYRK1ACCNT1
SCHEMBL3854840 0.76 MAP4K1 (0.46) MAP4K4PIK3CA
SCHEMBL3844989 0.72 MAP4K4 (0.34) MAP4K4RAF1BRAFDYRK1ACYP1A2
SCHEMBL3850082 0.72 CYP1A2 (0.42) MAP4K4DYRK1ACYP1A2CYP2D6CYP2C19
SCHEMBL3846904 0.71 CYP1A2 (0.38) MAP4K4RAF1BRAFDYRK1ACYP1A2
SCHEMBL3847327 0.71 SMN1; SMN2 (0.45) NOTUMLMNAALDH1A1HPGDMAPK1
SCHEMBL3850726 0.70 CYP1A2 (0.37) MAP4K4RAF1BRAFCYP1A2CYP2D6
SCHEMBL3853415 0.70 PIM1 (0.36) DYRK1ACYP1A2CYP2D6CYP2C19LMNA
Hydrochloric Acid SCHEMBL3849344 0.68 MAP4K4 (0.46) MAP4K4DYRK1ACYP1A2CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP claimed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US claimed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP claimed
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed